Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells

Journal of Leukocyte Biology

Volumn 98, Issue 5, 2015, Pages 689-702

  Yen, Jui Hung ^a   Kong, Weimin ^b   Hooper, Kirsten M ^b   Emig, Frances ^b   Rahbari, Kate M ^a,c   Kuo, Ping Chang ^a   Scofield, Barbara A ^a   Ganea, Doina ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cytokines; IRF1 IRF7; PI3K GSK3; STAT1 STAT2; Type I interferons

Indexed keywords

BETA INTERFERON; GLYCOGEN SYNTHASE KINASE 3; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 23; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; STAT1 PROTEIN; STAT2 PROTEIN; IL10 PROTEIN, MOUSE; IL12A PROTEIN, MOUSE; IRF1 PROTEIN, MOUSE; IRF7 PROTEIN, MOUSE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); PEPTIDE FRAGMENT; STAT1 PROTEIN, MOUSE; STAT3 PROTEIN; STAT3 PROTEIN, MOUSE; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL EXPANSION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPLEEN CELL; TH1 CELL; TH17 CELL; UPREGULATION; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; SPLEEN;

ANIMALS; DENDRITIC CELLS; GENE EXPRESSION REGULATION; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-7; INTERFERON-BETA; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-23; MICE; MICE, KNOCKOUT; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; SPLEEN; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TH17 CELLS; TOLL-LIKE RECEPTORS;

EID: 84946088757     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3HI0914-453R     Document Type: Article

References (44)

1. IFNB Multiple Sclerosis Study Group. (2001) Interferon beta-lb is effective in relapsing-remitting multiple sclerosis, I: clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. 1993 [classical article]. [classical article] Neurology 57(12):, Suppl 5)S3-S9.
2. Bendtzen, K. (2010) Critical review: assessment of interferon-b immunogenicity in multiple sclerosis. J. Interferon Cytokine Res. 30, 759-766.
3. Brod, S. A., Burns, D. K. (1994) Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons. Neurology 44, 1144-1148.
4. Guo, B., Chang, E. Y., Cheng, G. (2008) The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J. Clin. Invest. 118, 1680-1690.
5. Prinz, M., Schmidt, H., Mildner, A., Knobeloch, K. P., Hanisch, U. K., Raasch, J., Merkler, D., Detje, C., Gutcher, I., Mages, J., Lang, R., Martin, R., Gold, R., Becher, B., Br ück, W., Kalinke, U. (2008) Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28, 675-686.
6. Teige, I., Treschow, A., Teige, A., Mattsson, R., Navikas, V., Leanderson, T., Holmdahl, R., Issazadeh-Navikas, S. (2003) IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 170, 4776-4784.
7. Yu, M., Nishiyama, A., Trapp, B. D., Tuohy, V. K. (1996) Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. J. Neuroimmunol. 64, 91-100.
8. Makar, T. K., Trisler, D., Bever, C. T., Goolsby, J. E., Sura, K. T., Balasubramanian, S., Sultana, S., Patel, N., Ford, D., Singh, I. S., Gupta, A., Valenzuela, R. M., Dhib-Jalbut, S. (2008) Stem cell based delivery of IFN-beta reduces relapses in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 196, 67-81.
9. Axtell, R. C., de Jong, B. A., Boniface, K., van der Voort, L. F., Bhat, R., De Sarno, P., Naves, R., Han, M., Zhong, F., Castellanos, J. G., Mair, R., Christakos, A., Kolkowitz, I., Katz, L., Killestein, J., Polman, C. H., de Waal Malefyt, R., Steinman, L., Raman, C. (2010) T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 16, 406-412.
10. Dann, A., Poeck, H., Croxford, A. L., Gaupp, S., Kierdorf, K., Knust, M., Pfeifer, D., Maihoefer, C., Endres, S., Kalinke, U., Meuth, S. G., Wiendl, H., Knobeloch, K. P., Akira, S., Waisman, A., Hartmann, G., Prinz, M. (2012) Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS. Nat. Neurosci. 15, 98-106.
11. Sweeney, C. M., Lonergan, R., Basdeo, S. A., Kinsella, K., Dungan, L. S., Higgins, S. C., Kelly, P. J., Costelloe, L., Tubridy, N., Mills, K. H., Fletcher, J. M. (2011) IL-27 mediates the response to IFN-b therapy in multiple sclerosis patients by inhibiting Th17 cells. Brain Behav. Immun. 25, 1170-1181.
12. Teige, I., Liu, Y., Issazadeh-Navikas, S. (2006) IFN-b inhibits T cell activation capacity of central nervous system APCs. J. Immunol. 177, 3542-3553.
13. Galicia, G., Gommerman, J. L. (2014) Plasmacytoid dendritic cells and autoimmune inflammation. Biol. Chem. 395, 335-346.
14. Mohammad, M. G., Hassanpour, M., Tsai, V. W., Li, H., Ruitenberg, M. J., Booth, D. W., Serrats, J., Hart, P. H., Symonds, G. P., Sawchenko, P. E., Breit, S. N., Brown, D. A. (2012) Dendritic cells and multiple sclerosis: disease, tolerance and therapy. Int. J. Mol. Sci. 14, 547-562.
15. Goverman, J. (2009) Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9, 393-407.
16. Ransohoff, R. M., Engelhardt, B. (2012) The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 12, 623-635.
17. Zozulya, A. L., Clarkson, B. D., Ortler, S., Fabry, Z., Wiendl, H. (2010) The role of dendritic cells in CNS autoimmunity. J. Mol. Med. (Berl). 88, 535-544.
18. Svajger, U., Rozman, P. (2014) Tolerogenic dendritic cells: molecular and cellular mechanisms in transplantation. J. Leukoc. Biol. 95, 53-69.
19. Van Brussel, I., Lee, W. P., Rombouts, M., Nuyts, A. H., Heylen, M., De Winter, B. Y., Cools, N., Schrijvers, D. M. (2014) Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality? Autoimmun. Rev. 13, 138-150.
20. Kong, W., Yen, J. H., Vassiliou, E., Adhikary, S., Toscano, M. G., Ganea, D. (2010) Docosahexaenoic acid prevents dendritic cell maturation and in vitro and in vivo expression of the IL-12 cytokine family. Lipids Health Dis. 9, 12.
21. Brasel, K., De Smedt, T., Smith, J. L., Maliszewski, C. R. (2000) Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 96, 3029-3039.
22. Chang, J., Voorhees, T. J., Liu, Y., Zhao, Y., Chang, C. H. (2010) Interleukin-23 production in dendritic cells is negatively regulated by protein phosphatase 2A. Proc. Natl. Acad. Sci. U. S. A. 107, 8340-8345.
23. D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M., Trinchieri, G. (1993) Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178, 1041-1048.
24. Takaoka, A., Yanai, H. (2006) Interferon signalling network in innate defence. Cell. Microbiol. 8, 907-922.
25. Liu, J., Cao, S., Herman, L. M., Ma, X. (2003) Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)- gamma-primed IL-12 production by IFN regulatory factor 1. J. Exp. Med. 198, 1265-1276.
26. Tamura, T., Ozato, K. (2002) ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. J. Interferon Cytokine Res. 22, 145-152.
27. Sheikh, S. Z., Kobayashi, T., Matsuoka, K., Onyiah, J. C., Plevy, S. E. (2011) Characterization of an interferon-stimulated response element (ISRE) in the Il23a promoter. J. Biol. Chem. 286, 1174-1180.
28. Gabriele, L., Fragale, A., Borghi, P., Sestili, P., Stellacci, E., Venditti, M., Schiavoni, G., Sanchez, M., Belardelli, F., Battistini, A. (2006) IRF-1 deficiency skews the differentiation of dendritic cells toward plasmacytoid and tolerogenic features. J. Leukoc. Biol. 80, 1500-1511.
29. Martin, M., Rehani, K., Jope, R. S., Michalek, S. M. (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6, 777-784.
30. Wang, H., Brown, J., Garcia, C. A., Tang, Y., Benakanakere, M. R., Greenway, T., Alard, P., Kinane, D. F., Martin, M. (2011) The role of glycogen synthase kinase 3 in regulating IFN-b-mediated IL-10 production. J. Immunol. 186, 675-684.
31. Drulovic, J., Kostic, J., Mesaros, S., Dujmovic Basuroski, I., Stojsavljevic, N., Kisic-Tepavcevic, D., Pekmezovic, T. (2013) Interferon-beta and disability progression in relapsing-remitting multiple sclerosis. Clin. Neurol. Neurosurg. 115 (Suppl 1), S65-S69.
32. Durelli, L., Verdun, E., Barbero, P., Bergui, M., Versino, E., Ghezzi, A., Montanari, E., Zaffaroni, M.; Independent Comparison of Interferon (INCOMIN) Trial Study Group. (2002) Every-other-day interferon beta- 1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN). Lancet 359, 1453-1460.
33. Schmidt, H., Raasch, J., Merkler, D., Klinker, F., Krauss, S., Br ück, W., Prinz, M. (2009) Type I interferon receptor signalling is induced during demyelination while its function for myelin damage and repair is redundant. Exp. Neurol. 216, 306-311.
34. Yen, J. H., Ganea, D. (2009) Interferon beta induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation. Blood 114, 1344-1354.
35. Mittelstadt, M. L., Patel, R. C. (2012) AP-1 mediated transcriptional repression of matrix metalloproteinase-9 by recruitment of histone deacetylase 1 in response to interferon b. PLoS One 7, e42152.
36. Cortés-Vieyra, R., Bravo-Patiño, A., Valdez-Alarćon, J. J., Juárez, M. C., Finlay, B. B., Baizabal-Aguirre, V. M. (2012) Role of glycogen synthase kinase-3 beta in the inflammatory response caused by bacterial pathogens. J. Inflamm. (Lond). 9, 23.
37. Salem, M., Mony, J. T., Løbner, M., Khorooshi, R., Owens, T. (2011) Interferon regulatory factor-7 modulates experimental autoimmune encephalomyelitis in mice. J. Neuroinflammation 8, 181.
38. Haines, C. J., Chen, Y., Blumenschein, W. M., Jain, R., Chang, C., Joyce- Shaikh, B., Porth, K., Boniface, K., Mattson, J., Basham, B., Anderton, S. M., McClanahan, T. K., Sadekova, S., Cua, D. J., McGeachy, M. J. (2013) Autoimmune memory T helper 17 cell function and expansion are dependent on interleukin-23. Cell Reports 3, 1378-1388.
39. Źuñiga, L. A., Jain, R., Haines, C., Cua, D. J. (2013) Th17 cell development: from the cradle to the grave. Immunol. Rev. 252, 78-88.
40. Krakauer, M., Sorensen, P., Khademi, M., Olsson, T., Sellebjerg, F. (2008) Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression. Mult. Scler. 14, 622-630.
41. Ulusoy, C., Tüzün, E., Kürtüncü, M., Türkŏglu, R., Akman-Demir, G., Eraksoy, M. (2012) Comparison of the cytokine profiles of patients with neuronal-antibody-associated central nervous system disorders. Int. J. Neurosci. 122, 284-289.
42. VanDeusen, J. B., Shah, M. H., Becknell, B., Blaser, B. W., Ferketich, A. K., Nuovo, G. J., Ahmer, B. M., Durbin, J., Caligiuri, M. A. (2006) STAT-1-mediated repression of monocyte interleukin-10 gene expression in vivo. Eur. J. Immunol. 36, 623-630.
43. Liu, J., Guan, X., Tamura, T., Ozato, K., Ma, X. (2004) Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein. J. Biol. Chem. 279, 55609-55617.
44. Saraiva, M., O'Garra, A. (2010) The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170-181.